BioGaia AB: Year-end report January – December 2022
FOURTH QUARTER 2022 · Net sales amounted to SEK 274.3 million (206.2), an increase of SEK 68.1 million,...
Read moreFOURTH QUARTER 2022 · Net sales amounted to SEK 274.3 million (206.2), an increase of SEK 68.1 million,...
Read moreBioGaia's (NASDAQ: BIOG) financial report for the fourth quarter and full year of 2022 will be published at approximately...
Read moreTHIRD QUARTER 2022 · Net sales amounted to SEK 257.7 million (173.8), an increase of SEK 83.9 million,...
Read moreBioGaia's (NASDAQ: BIOG) financial report for the third quarter 2022 will be published at approximately 8:00 AM CEST...
Read moreBioGaia and Skinome have collaborated on the research and development of a product with live bacteria that can improve skin...
Read moreBioGaia is developing probiotic products and expanding its product portfolio with new bacterial strains, developed together with the wholly-owned...
Read moreSECOND QUARTER 2022 · Net sales amounted to SEK 288.1 million (203.1), an increase of SEK 85.0 million,...
Read more